Astragaloside II
Astragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
| Catalog Number | T3924 |
| Alternative Name(s) | Astrasieversianin VIII |
| Research Area | Stem Cells |
| Molecular Formula | C41H66O15 |
| CAS# | 84676-89-1 |
| Purity | 99.70% |
| SMILES | C(=O)(C)O[C@H]1[C@@H](OC[C@H]([C@@H]1O)O)O[C@H]1CC[C@]23C4(CC[C@]5([C@]([C@@H]4C[C@@H]([C@H]2C1(C)C)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)(C[C@@H]([C@@H]5[C@@]1(O[C@@H](CC1)C(C)(C)O)C)O)C)C)C3 |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/Astragaloside II |
| Additional Information | https://www.targetmol.com/datasheet/T3924 |